Nerinetide Reduces Early Infarct Growth Among Stroke Patients Undergoing EVT Without Intravenous Alteplase

Nerinetide Reduces Early Infarct Growth Among Stroke Patients Undergoing EVT Without Intravenous Alteplase

Background Nerinetide treatment was associated with better clinical outcomes among patients with stroke undergoing endovascular treatment who were not treated with concurrent alteplase in the randomized ESCAPE‐NA1 (Efficacy and Safety of Nerinetide for the Treatment of Acute Ischemic Stroke) trial....

Full description

Bibliographic Details
Main Authors: Nathaniel B. Rex, Johanna M. Ospel, Rosalie V. McDonough, Nima Kashani, Leon A. Rinkel, Brian H. Buck, Jeremy Rempel, Ryan A. McTaggart, Raul G. Nogueira, Alexandre Y. Poppe, Dar Dowlatshahi, Brian A. van Adel, Richard H. Swartz, Ruchir A. Shah, Eric Sauvageau, Andrew M. Demchuk, Michael Tymianski, Michael D. Hill, Mayank Goyal
Format: Article
Language:English
Published: Wiley 2024-03-01
Series:Stroke: Vascular and Interventional Neurology
Subjects:
thrombectomy
ischemic stroke
nerinetide
infarct growth
Online Access:https://www.ahajournals.org/doi/10.1161/SVIN.123.001034

Internet

https://www.ahajournals.org/doi/10.1161/SVIN.123.001034

Similar Items